Provided by Tiger Fintech (Singapore) Pte. Ltd.

Liminatus Pharma LLC

2.31
-0.3600-13.48%
Pre-market: 2.320.0100+0.43%06:34 EDT
Volume:521.43K
Turnover:1.27M
Market Cap:62.52M
PE:-16.95
High:2.60
Open:2.60
Low:2.30
Close:2.67
52wk High:33.66
52wk Low:2.30
Shares:27.06M
Float Shares:4.51M
Volume Ratio:0.71
T/O Rate:11.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1363
EPS(LYR):-0.0316
ROE:--
ROA:-54.40%
PB:-58980.47
PE(LYR):-73.11

Loading ...

Company Profile

Company Name:
Liminatus Pharma LLC
Exchange:
NASDAQ
Establishment Date:
2018
Employees:
- -
Office Location:
6 Centerpointe Drive,#625,La Palma,California,United States
Website:
- -
Zip Code:
90623
Fax:
- -
Introduction:
Iris Acquisition Corp does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as Tribe Capital Growth Corp I and changed its name to Iris Acquisition Corp in July 2022. The company was incorporated in 2020 and is based in George Town, Cayman Islands. Iris Acquisition Corp is a subsidiary of Iris Acquisition Holdings LLC.

Directors

Name
Position
Chris Kim
Chief Executive Officer and Director
Eun Sook Lee
Independent Director
Ji Yeon Baek
Independent Director
Nicholas Fernandez
Independent Director

Shareholders

Name
Position
Chris Kim
Chief Executive Officer and Director
Scott Dam
Chief Financial Officer
Beom K. Choi
Chief Technology Officer
Byong Chul Yoo
Chief Science Officer
Sang jin Daniel Lee
Head of Research and Development